ACET (Adicet Bio) 5-Year EBITDA Growth Rate: 22.50% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACET Adicet Bio Inc ACET
33 GF Score
Price $9.21
! 2 Warning Signs
View Full Analysis

What is Adicet Bio 5-Year EBITDA Growth Rate?

Adicet Bio ACET +3.64% 33 5-Year EBITDA Growth Rate is 22.50% as of Jun. 2026. GuruFocus rates ACET with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Adicet Bio's EBITDA per Share for the three months ended in Jun. 2026 was $-1.86.

During the past 3 years, the average EBITDA Per Share Growth Rate was 15.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 22.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Adicet Bio was 15.30% per year. The lowest was -64.00% per year. And the median was 13.60% per year.


Adicet Bio  (NAS:ACET) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Adicet Bio 5-Year EBITDA Growth Rate Related Terms


ACET vs ATRA, PYPD, GANX: 5-Year EBITDA Growth Rate Comparison

For the Biotechnology subindustry, Adicet Bio's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adicet Bio 5-Year EBITDA Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adicet Bio's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Adicet Bio's 5-Year EBITDA Growth Rate falls into.


ACET
33GF Score
Adicet Bio Inc ACET
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adicet Bio 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 22.50% mean?
Adicet Bio (ACET) has a 5-Year EBITDA Growth Rate of 22.50% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Adicet Bio and its competitors.
Is Adicet Bio's 5-Year EBITDA Growth Rate too high?
Adicet Bio's current 5-Year EBITDA Growth Rate is 22.50%. Overall, Adicet Bio has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Adicet Bio's 5-Year EBITDA Growth Rate compare to ATRA and PYPD?
Adicet Bio's 5-Year EBITDA Growth Rate of 22.50% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Biotechnology company?
A good 5-Year EBITDA Growth Rate depends on the Biotechnology industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Adicet Bio and its competitors. Adicet Bio's current 5-Year EBITDA Growth Rate is 22.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicet Bio stock overvalued right now?
Adicet Bio (ACET) has a current 5-Year EBITDA Growth Rate of 22.50%. The current 5-Year EBITDA Growth Rate is 22.50%. Adicet Bio's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Adicet Bio (ACET), the current 5-Year EBITDA Growth Rate is 22.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adicet Bio Business Description

Other Exchanges 0HX7:UK
Address 131 Dartmouth Street, 3rd Floor, Boston, MA, USA, 02116
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
33GF Score

Get the complete analysis for ACET

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.21
Price